Valuation: ICON Public Limited Company

Capitalization 1.4TCr 1.2TCr 1.12TCr 1.04TCr 1.94TCr 1,26400Cr 2.1TCr 13TCr 5.07TCr 60TCr 5.25TCr 5.14TCr 2,22800Cr P/E ratio 2025 *
27.2x
P/E ratio 2026 * 19.2x
Enterprise value 1.7TCr 1.46TCr 1.36TCr 1.27TCr 2.36TCr 1,53700Cr 2.55TCr 16TCr 6.16TCr 73TCr 6.38TCr 6.25TCr 2,70900Cr EV / Sales 2025 *
2.11x
EV / Sales 2026 * 2.02x
Free-Float
99.29%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.74%
1 week-9.03%
Current month+0.59%
1 month-1.76%
3 months-1.48%
6 months+21.77%
Current year+0.59%
More quotes
1 week 171.99
Extreme 171.99
191
1 month 171.99
Extreme 171.99
203.91
Current year 171.99
Extreme 171.99
203.91
1 year 125.1
Extreme 125.1
211
3 years 125.1
Extreme 125.1
347.72
5 years 125.1
Extreme 125.1
347.72
10 years 62.31
Extreme 62.31
347.72
More quotes
Manager TitleAgeSince
Director of Finance/CFO 53 01/10/2024
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer 51 01/07/2016
Director TitleAgeSince
Chairman 73 01/11/2002
Chairman 63 01/03/2017
Director/Board Member 65 25/11/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.74%-9.03%-15.92%-18.35% 1.4TCr
+0.66%+2.62%+4.95%+12.31% 4.91TCr
+0.29%+0.43%+18.05%+8.75% 4.11TCr
+5.11%+9.59%+90.16%+29.71% 3.88TCr
+3.27%+3.76%+25.05%+42.80% 3.27TCr
+2.37%+50.22%+181.77%+298.64% 2.32TCr
-26.23%-1.48%+24,147.39%+4,036.79% 1.61TCr
+1.54%-0.08%+72.84%+166.20% 1.71TCr
-0.57%+5.33%+57.73%+11.99% 1.5TCr
-2.67%-2.47%+127.48%+99.45% 1.29TCr
Average +0.89%+6.25%+2,470.95%+468.83% 2.6TCr
Weighted average by Cap. +0.70%+7.04%+1,543.55%+305.37%
See all sector performances

Financials

2025 *2026 *
Net sales 807.58Cr 693.95Cr 647.13Cr 601.32Cr 1.12TCr 73TCr 1.21TCr 7.44TCr 2.92TCr 35TCr 3.03TCr 2.97TCr 1,28500Cr 809.09Cr 695.25Cr 648.34Cr 602.45Cr 1.12TCr 73TCr 1.21TCr 7.45TCr 2.93TCr 35TCr 3.03TCr 2.97TCr 1,28800Cr
Net income 56Cr 48Cr 45Cr 42Cr 77Cr 5.04TCr 84Cr 513.88Cr 201.92Cr 2.41TCr 209.2Cr 204.91Cr 8.88TCr 68Cr 58Cr 54Cr 50Cr 94Cr 6.12TCr 101.58Cr 624.63Cr 245.43Cr 2.93TCr 254.28Cr 249.06Cr 11TCr
Net Debt 302.2Cr 259.68Cr 242.16Cr 225.01Cr 419.85Cr 27TCr 452.72Cr 2.78TCr 1.09TCr 13TCr 1.13TCr 1.11TCr 48TCr 234.42Cr 201.44Cr 187.85Cr 174.55Cr 325.69Cr 21TCr 351.19Cr 2.16TCr 848.55Cr 10TCr 879.14Cr 861.11Cr 37TCr
More financial data * Estimated data
Logo ICON Public Limited Company
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Employees
39,800
More about the company
Date Price Change Volume
13/26/13 183.29 $ +1.74% 8,68,209
12/26/12 180.15 $ -0.68% 8,86,994
09/26/09 181.38 $ -3.63% 14,33,953
08/26/08 188.22 $ -7.24% 33,40,765
07/26/07 202.92 $ +0.71% 7,06,283

Delayed Quote Nasdaq, January 14, 2026 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
183.29USD
Average target price
205.69USD
Spread / Average Target
+12.22%
Consensus

Quarterly revenue - Rate of surprise